Company

RNhale

Pharmaceutical Manufacturing Munich, Bavaria, De 7 employees

Employees: 7
Contacts: 1
Emails: 1

www.rnhale.com LinkedIn

RNhale Overview

Headquarters: Munich, Bavaria, De
Website: www.rnhale.com
Industry: Pharmaceutical Manufacturing
Employees: 7
Founded: 2023
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

siRNA dry powder formulation lipid nanoparticles

About RNhale

RNhale GmbH is a spin-off originating from the Ludwig-Maximilians-University Munich, aiming to revolutionize the pharmaceutical landscape by developing a unique platform technology for formulating RNA-loaded lipid nanoparticles (LNPs) as an inhalable dry powder. This disruptive approach synergizes technological and pharmaceutical strategies to create a novel therapeutic formulation with significant advantages over common LNP-RNA delivery methods. The target is pulmonary diseases with vast addressable markets and undeniable medical needs.

RNhale Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage

RNhale Org Chart

Sample employees and titles

Name	Title	Location	Contact
Benjamin Winkeljann	Engineer and Entrepreneur - Co-founder & CEO at Rnhale Gmbh - Group Leader Pharmaceutical Technology at Lmu Munich - Principal Investigator	Munich, Bavaria, Germany	View
Christine Schuberth-Wagner	Chief Scientific Officer at Catalym Gmbh, Biotech Start-up Coach and Mentor	Planegg, Bavaria, Germany	Email
Olivia Merkel	Professor and Chair of Drug Delivery at Lmu Munich		View
Serhat Bugra Kalkan	Master in Management at Tum - Mechanical Engineer		View